Assessment of Clinical Outcomes in Patients With Fibromyalgia: Analysis From the UK Medical Cannabis Registry
https://curaleafaustralia.com/wp-content/uploads/2026/06/Brain-Behaviour-1.webp
114
150
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Brain-Behaviour-1.webp
UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Attention-deficit/hyperactivity Disorder
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology-2.webp
595
782
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology-2.webp
Clinical Outcome Data of Anxiety Patients Treated With Cannabis-based Medicinal Products in the United Kingdom: A Cohort Study From the UK Medical Cannabis Registry
https://curaleafaustralia.com/wp-content/uploads/2026/06/Psychopharmacology.webp
155
204
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Psychopharmacology.webp
An Observational Study of Clinical Outcome Measures in Patients Treated With Cannabis-based Medicinal Products on the UK Medical Cannabis Registry
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology-1.webp
595
782
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology-1.webp
Real World Evidence in Medical Cannabis Research
https://curaleafaustralia.com/wp-content/uploads/2026/06/Therapeutic-Innovation-Regulatory-Science.webp
158
209
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Therapeutic-Innovation-Regulatory-Science.webp
UK Medical Cannabis Registry: A Case Series Analyzing Clinical Outcomes of Medical Cannabis Therapy for Generalized Anxiety Disorder Patients
https://curaleafaustralia.com/wp-content/uploads/2026/06/International-Clinical-Psychopharmacology-1.webp
298
397
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/International-Clinical-Psychopharmacology-1.webp
Comparing the Effects of Medical Cannabis for Chronic Pain Patients With and Without Co-morbid Anxiety: A Cohort Study
https://curaleafaustralia.com/wp-content/uploads/2026/06/Expert-Review-of-Neurotherapeutics-1.webp
200
261
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Expert-Review-of-Neurotherapeutics-1.webp
Assessment of Clinical Outcomes in Patients With Inflammatory Arthritis: Analysis From the UK Medical Cannabis Registry
https://curaleafaustralia.com/wp-content/uploads/2026/06/International-Clinical-Psychopharmacology.webp
298
397
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/International-Clinical-Psychopharmacology.webp
A Cohort Study Comparing the Effects of Medical Cannabis for Anxiety Patients With and Without Comorbid Sleep Disturbance
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology.webp
595
782
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Neuropsychopharmacology.webp
Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study
https://curaleafaustralia.com/wp-content/uploads/2026/06/Journal-of-Pain-Palliative-Care-Pharmacotherapy-1.webp
200
259
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Journal-of-Pain-Palliative-Care-Pharmacotherapy-1.webp
UK Medical Cannabis Registry: A Cohort Study of Patients Prescribed Cannabis-based Oils and Dried Flower for Generalised Anxiety Disorder
https://curaleafaustralia.com/wp-content/uploads/2026/06/Expert-Review-of-Neurotherapeutics.webp
200
261
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Expert-Review-of-Neurotherapeutics.webp
UK Medical Cannabis Registry: An Updated Analysis Of Clinical Outcomes Of Cannabis-based Medicinal Products For Inflammatory Bowel Disease
https://curaleafaustralia.com/wp-content/uploads/2026/06/Expert-Review-of-Gastroenterology-Hepatology.webp
200
259
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Expert-Review-of-Gastroenterology-Hepatology.webp
UK Medical Cannabis Registry: A Clinical Outcome Analysis of Medical Cannabis Therapy in Chronic Pain Patients With and Without Co-morbid Sleep Impairment
https://curaleafaustralia.com/wp-content/uploads/2026/06/pain-practice.webp
595
782
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/pain-practice.webp
UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Cancer Pain
https://curaleafaustralia.com/wp-content/uploads/2026/06/Journal-of-Pain-Palliative-Care-Pharmacotherapy.webp
200
259
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/Journal-of-Pain-Palliative-Care-Pharmacotherapy.webp
UK Medical Cannabis Registry: An Analysis of Outcomes of Medical Cannabis Therapy for Hypermobility-Associated Chronic Pain
https://curaleafaustralia.com/wp-content/uploads/2026/06/ACR-Open-Rheumatology.webp
612
792
Curaleaf Australia
https://curaleafaustralia.com/wp-content/uploads/2026/06/ACR-Open-Rheumatology.webp














